Rob Burke
41Patents
10h-index
26Co-inventors
71Inventor score
Filing activity: Nov 3, 2014 → Jan 2, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10550188B2 | Nucleic acid-polypeptide compositions and uses thereof | Chemistry; Metallurgy | 69 | Active |
| US10881743B2 | Compositions and methods of treating muscle atrophy and myotonic dystrophy | Chemistry; Metallurgy | 45 | Active |
| US11179472B2 | Nucleic acid-polypeptide compositions and methods of inducing exon skipping | Chemistry; Metallurgy | 28 | Active |
| US10994020B2 | Nucleic acid-polypeptide compositions and methods of inducing exon skipping | Chemistry; Metallurgy | 25 | Active |
| US11311627B1 | Nucleic acid-polypeptide compositions and methods of inducing exon skipping | Chemistry; Metallurgy | 21 | Active |
| US11400163B2 | Nucleic acid-polypeptide compositions and methods of inducing exon skipping | Chemistry; Metallurgy | 19 | Active |
| US10487149B2 | Nucleic acid-polypeptide compositions and uses thereof | Chemistry; Metallurgy | 17 | Active |
| US10787519B2 | Nucleic acid-polypeptide compositions and uses thereof | Chemistry; Metallurgy | 17 | Active |
| US11110180B2 | Nucleic acid-polypeptide compositions and uses thereof | Chemistry; Metallurgy | 16 | Active |
| US12064483B2 | Nucleic acid-polypeptide compositions and methods of inducing exon skipping | Chemistry; Metallurgy | 13 | Active |
| US11555190B2 | Compositions and methods of treating Facioscapulohumeral muscular dystrophy | Chemistry; Metallurgy | 10 | Active |
| US11525137B2 | Compositions and methods of treating Facioscapulohumeral muscular dystrophy | Chemistry; Metallurgy | 9 | Active |
| US11253607B2 | Compositions and methods of treating muscle atrophy and myotonic dystrophy | Chemistry; Metallurgy | 7 | Active |
| US11246941B2 | Compositions and methods of treating muscle atrophy and myotonic dystrophy | Chemistry; Metallurgy | 7 | Active |
| US10800848B2 | Nucleic acid-polypeptide compositions and uses thereof | Chemistry; Metallurgy | 6 | Active |
| US11576980B2 | Compositions and methods of treating muscle atrophy and myotonic dystrophy | Chemistry; Metallurgy | 5 | Active |
| US11912779B2 | Compositions and methods of treating facioscapulohumeral muscular dystrophy | Chemistry; Metallurgy | 4 | Active |
| US11446387B2 | Compositions and methods of treating muscle dystrophy | Chemistry; Metallurgy | 4 | Active |
| US10010562B2 | Dual molecular delivery of oligonucleotides and peptide containing conjugates | Chemistry; Metallurgy | 2 | Active |
| US10532068B2 | Dual molecular delivery of oligonucleotides and peptide containing conjugates | Chemistry; Metallurgy | 2 | Active |
| US11497814B2 | Compositions and methods of treating muscle atrophy and myotonic dystrophy | Chemistry; Metallurgy | 2 | Active |
| US11554176B2 | Compositions and methods of treating muscle atrophy and myotonic dystrophy | Chemistry; Metallurgy | 2 | Active |
| US11364302B1 | Nucleic acid-polypeptide compositions and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11707532B2 | Compositions and methods of treating muscle dystrophy | Chemistry; Metallurgy | 1 | Active |
| US11583591B2 | Compositions and methods of treating muscle atrophy and myotonic dystrophy | Chemistry; Metallurgy | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.